Phase 2
Completed N=24
Comparison of Retinol 1.0% and Tretinoin 0.02% in the Treatment of Moderate to Severe Photodamage and Wrinkles
Photodamaged Skin · Wrinkles
Source: ClinicalTrials.gov NCT01283464 ↗
Enrolled (actual)
24
Serious AEs
12.5%
Results posted
Aug 2013
Primary outcomePrimary: Global Photodamage Severity — 4.8; 5.45 units on a scale
Summary
The purpose of this study is to assess the comparative efficacy of retinol 1.0% and tretinoin 0.02% in minimizing wrinkles, discoloration, roughness, and other signs of moderate to severe photodamage. Our hypothesis is that both products will be of comparable benefit.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Global Photodamage Severity |
4.8; 5.45 | — |
Eligibility Criteria
Inclusion Criteria
- Age 35 or over
- Moderate to severe photodamage
Exclusion Criteria
- History of facial cosmetic surgery, facial resurfacing procedures, deep peels, or facial fillers
- History of keloids or hypertrophic scars
- Use of oral steroids or oral retinoids (such as Accutane) in past 6 months
Data sourced from ClinicalTrials.gov (NCT01283464). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.